sahin.io

Investors

Who Invested in Trestle Biotherapeutics?

Trestle Biotherapeutics is backed by Y Combinator, according to public sources.

Bioengineered therapies for Kidney Disease

Company ValueNot published
MarketBiotech
Known Investors1
StatusLive

Angel Investor

Sahin Boydas

Angel Investor · 231 companies across 14 categories

Investors in Trestle Biotherapeutics include Y Combinator. Of its investors, it is in the most other companies in Sahin’s portfolio.

Institutional Investors in Trestle Biotherapeutics

Angel Investor: Sahin Boydas

Sahin Boydas

#1 most active angel investor in the U.S. in 2024 (Lenny's Newsletter)

Companies
231
Categories
14
$1B+ Companies
46
Biotech Companies
10

Why Angel Investors Matter for Trestle Biotherapeutics

Angel investors like Sahin Boydas provide more than capital to companies like Trestle Biotherapeutics. They bring early-stage validation, industry connections, and strategic guidance that help startups navigate from idea to product-market fit. Trestle Biotherapeutics is part of a broader thesis on the Biotech market, where the public portfolio holds 10 companies in total. Each named investor links to its own public directory where one exists.

Angel investors typically invest at the earliest stages, when risk is highest but potential returns are greatest. Trestle Biotherapeutics’s progress reflects the early conviction that angel investors placed in the company's vision and team.

View the Trestle Biotherapeutics profile

BiotechHealthTherapeuticsLive

This evidence-based directory lists investors in the sources below. It may not be complete.

Return to Trestle Biotherapeutics profile

Trestle Biotherapeutics investors: questions and answers

Who invested in Trestle Biotherapeutics?

Trestle Biotherapeutics is backed by Y Combinator, according to public sources.

Which venture capital firms invested in Trestle Biotherapeutics?

Venture capital firms named as investors in Trestle Biotherapeutics: Y Combinator.

Which angel investors backed Trestle Biotherapeutics?

Sahin Boydas is an angel investor in Trestle Biotherapeutics, one of 231 companies in Sahin Boydas’s public angel portfolio.

Where does the list of Trestle Biotherapeutics investors come from?

Every investor on this page is cited to a public source, such as Trestle Biotherapeutics and Y Combinator. Only investors named in public reporting are listed, so the list may not be complete.

Browse more investors

Other Biotech companies with investors